Policy & Regulation

According to the U.S. Federal Register, on August 23, 2024, the U.S. Environmental Protection Agency (EPA) officially issued Regulation 2024-19000, revising the residue limits of Ethaboxam in certain foods.

The US Food and Drug Administration (FDA) officially approved an updated version of the COVID-19 vaccines developed by Pfizer (PFE.US) and Moderna (MRNA.US) last Thursday.

According to recent reports, the Nigerian Customs Service issued a document on August 15, 2024, announcing that it would implement a zero-duty policy on imports of certain basic foodstuffs.

The Ministry of Food and Drug Safety (MFDS) issued Notice No. 2024-386 on August 21, 2024, announcing plans to revise the current Regulations on Functional Raw Materials and Certification of Standards and Specifications for Health Functional Food.

On August 9, 2024, the Ministry of Food and Drug Safety (MFDS) of South Korea announced plans to expand the scope of food nutrition labels to cover all processed foods.

In recent days, the long-standing patent dispute between Pfizer and AZ has finally come to an end.

On August 12, 2024, the Turkish Food Safety and Control Authority officially issued Notice No. 585, No. 586, and No. 587, planning to draft three food regulations and setting the feedback period from September 16, 2024, to the same date.

Hengrui Pharmaceutical's global first-in-class generic drug bupivacaine liposome injection has received FDA approval for marketing in the US, becoming the first company to receive such approval in the US.

South Korea's exports of rice-processed food surged 45.8% year-on-year to $166.12 million in the January-July period, setting a new record high for the same period.

According to the latest report released by Future Market Insights, the pharmaceutical grade sodium chloride market is expected to experience significant growth over the next decade and is expected to reach a market size of $618 million by 2034.

Lykos Therapeutics' original application was based on the positive results of two advanced clinical trials that combined MDMA with talk therapy to treat PTSD.

The core of this regulation is to explicitly prohibit health claims on foods containing monacolin K in red yeast rice that "contribute to the maintenance of normal blood LDL cholesterol concentrations."

Recently, the northeast and northwest regions of China, as the main supply and export areas of butene-1, have reduced the supply, resulting in a decline in the overall supply of the Chinese market.

In 2022, Gilead announced that it would voluntarily withdraw Zydelig from the U.S. market for two lymphoma treatments, a full six years after it suspended the trial due to patient deaths.

Market analysts pointed out that the global phenol and acetone market prices are expected to remain low in the second half of 2024.

The development of semaglutide, a miracle drug, is a saga of challenges and breakthroughs.

Recently, the US Food and Drug Administration (FDA) issued an important import alert notice on its official website, which has attracted wide attention from the international community.

Novo Nordisk is proud to announce that its weight loss drug Wegovy has been approved by the European Medicines Agency (EMA) for the prevention of stroke and heart disease.

MFDS issued an important announcement, Announcement 2024-41, announcing a comprehensive and in-depth revision of the existing food standards and codes, aimed at enhancing the transparency of food labeling and enhancing consumers' right and freedom.

On July 24, 2024, the European Food Safety Authority (EFSA) officially published the official document 2024.8944, which aims to comprehensively revise and adjust the regulations on the use of triacylglycerol lipase.